Cargando…

Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr (-/-) mice, thereby accelerating hepatic fibrosis

OBJECTIVE: Chronic ethanol consumption is known to cause alcohol-associated liver disease, which poses a global health concern as almost a quarter of heavy drinkers develop severe liver damage. Alcohol-induced liver disease ranges from a mild, reversible steatotic liver to alcoholic steatohepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoebinger, Constanze, Rajcic, Dragana, Silva, Beatriz, Hendrikx, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407564/ https://www.ncbi.nlm.nih.gov/pubmed/37560305 http://dx.doi.org/10.3389/fendo.2023.1148827

Ejemplares similares

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

STING‐mediated inflammation contributes to Gao binge ethanol feeding model
por: Wang, Ling, et al.
Publicado: (2021)

Ethanol binge drinking exposure affects alveolar bone quality and aggravates bone loss in experimentally-induced periodontitis
por: Frazão, Deborah Ribeiro, et al.
Publicado: (2020)

APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study
por: de Freitas, Rossana Ghessa Andrade, et al.
Publicado: (2015)

Role of the Gut in Diabetic Dyslipidemia
por: Stahel, Priska, et al.
Publicado: (2020)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

Sodium Butyrate Supplementation Modulates Neuroinflammatory Response Aggravated by Antibiotic Treatment in a Mouse Model of Binge-like Ethanol Drinking
por: Gao, Lei, et al.
Publicado: (2022)

Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review
por: Vukovic, Rade, et al.
Publicado: (2019)

Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022)

The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells
por: Sun, Yi, et al.
Publicado: (2019)

Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
por: Tu, Powen, et al.
Publicado: (2009)

LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia
por: Eroglu, Zuhal, et al.
Publicado: (2016)

Influenza A Virus Weakens the Immune Response of Mice to Toxoplasma gondii, Thereby Aggravating T. gondii Infection
por: Chen, Junpeng, et al.
Publicado: (2023)

17β-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER/PLC Activation in HepG2 Cells
por: Fu, Wei, et al.
Publicado: (2020)

Effect of Washed Microbiota Transplantation on Patients With Dyslipidemia in South China
por: Liang, Fenfen, et al.
Publicado: (2022)

From binge eating to binge drinking: A new and robust paradigm for assessing binge ethanol self‐administration in male rats
por: Ruiz‐Leyva, Leandro, et al.
Publicado: (2022)

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation
por: Jiang, Xue, et al.
Publicado: (2022)

Transcriptomics reveals amygdala neuron regulation by fasting and ghrelin thereby promoting feeding
por: Peters, Christian, et al.
Publicado: (2023)

LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis
por: Shi, Xiangguang, et al.
Publicado: (2022)

Increased ethanol consumption after interruption of fat bingeing
por: Blanco-Gandía, M. Carmen, et al.
Publicado: (2018)

Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice
por: Ramirez-Hernandez, Gabriela, et al.
Publicado: (2021)

Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives
por: Rao, Hussain, et al.
Publicado: (2021)

Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity
por: Xu, Tiantian, et al.
Publicado: (2022)

Episodic Binge-like Ethanol Reduces Skeletal Muscle Strength Associated with Atrophy, Fibrosis, and Inflammation in Young Rats
por: Cáceres-Ayala, Constanza, et al.
Publicado: (2023)

Neurosteroid Influences on Sensitivity to Ethanol
por: Helms, Christa M., et al.
Publicado: (2012)

A proteomic analysis of liver after ethanol binge in chronically ethanol treated rats
por: Aroor, Annayya R, et al.
Publicado: (2012)

Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
por: Yue, Jiang, et al.
Publicado: (2021)

Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
por: Zhang, Guangyang, et al.
Publicado: (2022)

Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
por: Song, Youhyun, et al.
Publicado: (2022)

Association Between Dyslipidemia and Helicobacter Pylori Infection
por: Hayes Dorado, Juan Pablo
Publicado: (2021)

A Group Intervention for Individuals With Obesity and Comorbid Binge Eating Disorder: Results From a Feasibility Study
por: Eik-Nes, Trine T., et al.
Publicado: (2021)

Aqueous extract of Laurus nobilis leaf accelerates the alcohol metabolism and prevents liver damage in single-ethanol binge rats
por: Jung, Jae In, et al.
Publicado: (2023)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Exercise Enhances Hippocampal Recovery following Binge Ethanol Exposure
por: Maynard, Mark E., et al.
Publicado: (2013)

Investigation of Sex Differences in the Microglial Response to Binge Ethanol and Exercise
por: Barton, Emily A., et al.
Publicado: (2017)

Chronic constant light exposure aggravates high fat diet-induced renal injury in rats
por: Xing, Lin, et al.
Publicado: (2022)

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
por: Coccurello, Roberto, et al.
Publicado: (2020)

Dyslipidemia and 10-year diabetes incidence in Japanese people: Population-based Panasonic cohort study 9
por: Kobayashi, Genki, et al.
Publicado: (2022)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2shg9brkjb7it4kbphvjcrd4j